A panel organized by the FDA cast doubts on the safety of antidepressants during pregnancy — drawing ire from doctors who say ...

An unusual FDA panel on antidepressant use during pregnancy elevated clinicians and researchers who are deeply skeptical of ...

Ozempic (semaglutide) and other GLP-1 medications have helped many people lose weight and manage chronic conditions like type ...

Members of an advisory panel have proposed adding warning labels to some medication about adverse maternal and fetal risks in ...

On Monday morning, the FDA hosted a 10-person expert panel on the use during pregnancy of SSRIs, which include medications ...

At a recent FDA panel on SSRIs in pregnancy, the chair suggested rising antidepressant use may be contributing to — not ...

NBC News medical contributor Dr. Natalie Azar reports on the FDA panel discussion of the use of antidepressants during ...

FDA issues warning for unapproved chemical being used for anxiety, depressionPhase one of Evergreen Bike Park opening Aug. 21 in Rothschild ...

A new patch to treat severe adult depression was recently approved by the Food and Drug Administration, similar to the Nicotine patch and birth-control patch, will allow patients to have more dietary ...

Currently, there's only one drug on the market that's FDA-approved to treat postpartum depression. The drug, called Zulresso, is only available through 60-hour, one-time infusion, and can cost as ...

The FDA approved the first pill to treat postpartum depression on Aug. 4, offering a new treatment option for 500,000 women who develop the condition annually.